A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Bibliografske podrobnosti
Glavni avtor:	Islam, Nahidul
Drugi avtorji:	Talukder, Mesbah
Format:	Thesis
Jezik:	English
Izdano:	Brac University 2023
Teme:	Psoriasis Biologics FAERS Interleukin inhibitors Alopecia Pharmacovigilance
Online dostop:	http://hdl.handle.net/10361/22025

Podobne knjige/članki

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
od: Afroza, Halima
Izdano: (2024)

Biologics and Biosimilars as Treatment Options for Psoriasis
od: Moya, Amena Khatun
Izdano: (2023)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
od: Bishakha, Adwiza Chakraborty
Izdano: (2024)

Safety and efficacy of dutasteride for male Androgenetic Alopecia
od: Islam, S.M. Zahidul
Izdano: (2024)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
od: Khandker, Tahia Anjum
Izdano: (2024)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)
od: Onanna, Kazi
Izdano: (2024)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
od: Nusrat, Tanzina
Izdano: (2019)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
od: Rahman, Ahadina
Izdano: (2018)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
od: Meem, Manila
Izdano: (2023)

A review on potential of PARP inhibitors in the treatment of prostate cancer
od: Islam, Saidul
Izdano: (2022)

A survey on the knowledge and attitude on pharmacovigilance among the pharmacy students of different universities of Dhaka, Bangladesh
od: Albee, Md. Hamza
Izdano: (2017)

Identification of FAP inhibitors using in silico simulation study
od: Deeba, Maliha Tasnim
Izdano: (2018)

A review on newly approved PARP inhibitors: Talazoparib and Olaparib
od: Karim, Azrin
Izdano: (2024)

Efficacy and safety of monotherapy and combination therapy of oral minoxidil for androgenetic alopecia: a structured review
od: Jahan, Safrin
Izdano: (2023)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
od: Tabassum, Nadira
Izdano: (2024)

Pharmacokinetics, safety, efficacy and immunogenicity of Adalimumab biosimilar ABP-501in rheumatoid arthritis and plaque psoriasis
od: Akter, Anika
Izdano: (2022)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
od: Shehab, Habibul Mohsin
Izdano: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
od: Haque, Mushfiqul
Izdano: (2019)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
od: Bakar, Osama Bin Abu
Izdano: (2024)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
od: Flora, Sanzida Alam
Izdano: (2024)

A review on Bruton's Tyrosine Kinase inhibitors to outline the scopes of further advancements in the treatment of cancer
od: Khan, Muidul Hasan
Izdano: (2024)

Biomarkers in the diagnosis and treatment of Covid-19
od: Kabir, Syeda Shuvessa
Izdano: (2023)

A review on the role of Epigenetics in Psychiatry: Etiology, contemporary medicine and future perspectives
od: Oshin, Sadia Afrin
Izdano: (2021)

Effect Of sodium glucose co-transporter 2 inhibitors on weight reduction in overweight and obese population: A review
od: Mahin, Md. Tamjidur Rahman
Izdano: (2024)

Female Alopecia
od: TrÃ¼eb
Izdano: (2013)

RIPK pathway, as a potential target, for cancer treatment - a review
od: Jahan, Nusrat
Izdano: (2024)

Study on anticancer drugs approved by the FDA from 2014 to 2023
od: Rattry, Faria Rahman
Izdano: (2024)

Recent advancement of biologics in Asthma
od: Evan, Al- Shahriar
Izdano: (2022)

A review on cyclin-dependent kinase 7 (CDK7) Inhibitors as anticancer agents
od: Sorno, Rubina Haque
Izdano: (2024)

Cross-sectional survey to assess the knowledge, attitude and practice regarding adverse drug reactions of students of a private university
od: Islam, Tarikul
Izdano: (2021)

A study on drug product approval by the FDA from 1930 to 2019
od: Jony, Md. Nazmul Islam
Izdano: (2023)

Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
od: Hossain, Ragib
Izdano: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
od: Emon, Kamrul Hasan
Izdano: (2022)

FDA Consumer

FDA Consumer

FDA Consumer

FDA Consumer

Detection of skin diseases using deep learning
od: Shodoy, Masuk Ur Rahman
Izdano: (2024)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
od: Paul, Sanjoy Kumer
Izdano: (2021)

Pharmacoepidemiology and Pharmacovigilance